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Abstract
Background: Opportunistic infections and malignancies cause lymphadenopathy in HIV-infected patients. The
use and accuracy of  fine needle aspiration cytology in diagnosing of  cervical lymphadenopathy among HIV-infected patients 
is not well studied in Uganda.
Objective: The aim of  this study was to determine the diagnostic accuracy of  fine needle aspiration cytology in providing a 
diagnosis of  cervical lymphadenopathy among HIV-infected patients in Uganda.
Methods: We consecutively recruited adult HIV-infected patients with cervical lymphadenopathy admitted to Mulago Hos-
pital medical wards. Clinical examination, fine needle aspiration and lymph node biopsy were performed. We estimated the 
sensitivity, specificity; negative and positive predictive values using histology as the gold standard.
Results: We enrolled 108 patients with a mean age of  33 years (range, 18-60), 59% were men and mean CD4 was 83(range, 
22-375) cells/mm3. The major causes of  cervical lymphadenopathy were: tuberculosis (69.4%), Kaposi's sarcoma-KS (10.2%) 
and reactive adenitis (7.4%). Overall fine needle aspiration cytology accurately predicted the histological findings in 65 out 
of  73 cases (89%) and missed 7 cases (9.5%). With a sensitivity of  93.1%, specificity of  100%, positive predictive value of  
100% and negative predictive value of  78.7% for tuberculosis and 80%; 98.4%;88.9% and 98.9% for KS respectively. No 
fine needle aspiration complications were noted.
Conclusions: Fine needle aspiration cytology is safe and accurate in the diagnosis of  tuberculosis and KS cervical lymphad-
enopathy among HIV-positive patients.
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Introduction
Significant asymmetrical lymphadenopathy is a com-
mon problem in HIV infected adults. In  developing 
countries  with  a  high  incidence  of   tuberculosis, 
tuberculous  lymphadenitis (TBLN) is one of  the most 
frequent causes of  lymphadenopathy and occurs with 
increased frequency in  HIV positive individuals.1-3  Sev-
eral other opportunistic infections can present similar-
ly  including;   Cryptococcus  infection,  toxoplasmosis 
and   pyogenic  infections.   In HIV/AIDS patients, 
there is also an increased risk of  development of  malig-
nancies such as Kaposi’s sarcoma (KS) and non-Hodg-
kin’s lymphoma (NHL) which may present similarly4, 5.
In the past decade, fine needle aspirate cytology (FNAC) 
has assumed an important role in the diagnosis of  pe-
ripheral lymphadenopathy as an alternative procedure 
which is less invasive, faster and cheaper than excision 
biopsy.6-8 Unfortunately, FNAC has not been widely 
utilized in Uganda, as most clinicians still use surgical 
excision biopsies.  Such biopsies are fairly invasive; need 
more resources, and a longer time to diagnosis. Diag-
nostic accuracy of  FNAC with its pitfalls has been ex-
tensively reviewed by Schmidt.9  He argues that a set 
standard should be followed and in the design and re-
porting of  these studies to avoid bias. FNAC has gen-
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erally been found to be accurate in diagnosing different 
aetiologies in HIV-infected patients but most of  these 
studies have been retrospective.9,10
The diagnostic accuracy of  FNAC among HIV-infect-
ed patients with cervical lymphadenopathy in Uganda 
is largely unknown; neither do we know the leading 
causes of  lymphadenopathy in this patient population. 
There is therefore need to ascertain the accuracy and 
causes of  cervical lymphadenopathy and to evaluate 
simpler, less invasive methods for making a diagnosis. 
We hypothesized that FNAC is as good as histology in 
the diagnosis of  lymphadenopathy among HIV-posi-
tive patients. We determined the diagnostic accuracy of  
FNAC in the evaluation of  cervical lymphadenopathy 
in adult HIV-infected patients and established the com-
mon causes in Mulago national referral hospital.
Methods
Participants
This was a cross-sectional study of  diagnostic accuracy 
in which we consecutively recruited adult  HIV-infected 
patients  with  cervical  lymphadenopathy who  were 
admitted  to  Mulago national referral hospital medi-
cal wards in Kampala, Uganda, between February 2007 
and June 2007. Mulago national referral hospital is one 
of  two national referral hospitals. It is located in the 
center of  the capital city of  the country called Kam-
pala. The hospital admits most of  the HIV- infected 
patients from the surrounding specialist centers as well 
as other hospitals throughout the country. HIV testing 
is routinely provided to all the patients that are admitted 
through the emergency unit on an ‘opt out’ basis.
We included patients who were 18 years or older and 
had documented HIV-1 infection with cervical lym-
phadenopathy (considered as the largest lymph node 
diameter > 1 centimeter). Patients  with  a  prior  his-
topathologic  diagnosis  of   their  cervical  lympahade-
nopathy  were excluded from the study. 
 
We interviewed participants using a structured ques-
tionnaire to obtain information on the socio- demo-
graphic  characteristics,  history of  prior  treatment  for 
TB  or  any  other  opportunistic infection as well as 
the presence of  fever, cough for more than two weeks, 
night sweats and loss of  weight.
Study  physicians  examined  participants  to  assess  the 
location,  number  and  consistency of  enlarged cervical 
lymph nodes, as well as height, weight, Karnosky score, 
and WHO HIV stage. Blood was drawn for CD4 T cell 
count testing.
Test methods
Histology of  the lymph node aspirate was used as the 
gold standard for all the aetiological diagnoses. We per-
formed fine needle aspiration on the cervical lymph 
node of  each participant. Under sterile conditions, we 
used a 23-gauge needle and 10 ml syringe for aspiration 
of  the largest node, allowing 3-5 passes through the 
node. The aspirate was flushed onto a slide and spread 
to make a thin smear, taking precautions to avoid con-
tamination especially to the eyes.
Next local anesthetic was infiltrated in the skin above a 
selected non-fluctuant lymph node that was easily ac-
cessible for biopsy. Under sterile conditions, the node 
was biopsied and put in a container with 10% formalin 
for histological processing and examination. Any dis-
comfort or side effects were monitored over the next 
four hours. The time taken to perform the FNA, biopsy 
and cytology were recorded.
The aspirated material was spread on five glass slides. 
One slide was fixed immediately with 95% ethyl alco-
hol, and the rest were air dried. The alcohol fixed slide 
was stained by haematoxylin and eosin (H&E) stain for 
cytological examination. For the air dried slides, one 
was for Ziehl Neelsen (ZN) staining to look for Acid 
Alcohol Fast Bacilli (AAFB) and the other slides were 
stained by Diff  Quick stain for cytological examination 
at a later time. Cytology and histology was performed 
by a senior and experienced pathologist who has been 
doing similar work using the set criteria outlined be-
low. For each of  the specimen AAFB microscopy and 
cytology were done first and later histology was done 
with blinding to the first set of  results. In each case a 
summary of  clinical information was made available to 
the pathologist. 
For quality control 10% of  the specimen were randomly 
selected and reviewed by an independent senior pathol-
ogist.  Histological  diagnosis  of   TB  was  made  basing 
on  at  least  one  of   the  three histological findings 
including: caseous necrosis, fibrosis or granulomas.11 
Diagnosis of  KS was based on finding clusters or single 
spindle cells and or plump cells in a back ground of  nu-
merous red blood cells and mature lymphocytes.12 The 
Reed Sternberg cells and “popcorn” cells formed the 
basis for diagnosis of  Hodgkin’s disease. Reactive adeni-
tis was based on finding mixed population of  lymphoid 
cells on histology of  the lymph node tissue. The cyto-
logical diagnosis of  toxoplasmosis was made based on 
seeing tangible body macrophages and a background of  
mature lymphocytes, predominantly small lymphocytes.
Statistical analysis
All data was double entered into Epi-Info version 6.04 
and analysed using SPSS 10.0 software.
Descriptive statistics were used to summarize baseline 
characteristics of  the study patients, into means, medi-
ans, proportions, and standard deviations. The diagnos-
tic yield of  the 2 procedures was compared by diagno-
sis. To determine the diagnostic accuracy of  FNAC in 
the evaluation of  aetiology of  cervical lymphadenop-
athy; we estimated the sensitivity, specificity; negative 
and positive predictive values using histology as the 
gold standard.
Ethical approval
The study was approved by the Faculty of  Medicine 
Research and Ethics Committee of  the School of  Med-
icine, Makerere University College of  Health Sciences 
and the Uganda National Council for Science and Tech-
nology and written informed consent was obtained 
from all study participants.
Results
Between February 2007 and June 2007, 1286 patients 
with HIV infection were admitted to medical wards 
at Mulago National Referral Hospital in Kampala and 
screened for enrolment (see figure 1).  Among the en-
rolled 108 patients, the mean age was 33 years (Range 
18-60 years) and 59% were men. Thirty nine patients 
(36.2%) had generalized lymphadenopathy while sixty 
nine (63.9) had only cervical lymphadenopathy.
Figure 1 Patient Flow Chart
2,580 pts admitted on the medical wards
1294 excluded from the study
. 1290 HIV negative
1,282 pts screened and examined
1,174 pts excluded
•    1,173 No significant lymphadenopathy
•    1 had prior cervical histopathological exam
108pts with significant lymphadenopathy
108 pts had FNA and ZN
73 pts had biopsy done
Abbreviations: HIV, Human Immunodeficiency virus; Pts-patients, ZN, Zeihl Neelsen stain
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Seventy four patients (68.5%) had tested for HIV with-
in the past one year and with 107 (99.1%) presenting as 
advanced WHO HIV stage III and IV. The mean CD4 
count for the study patients was  83  (range, 22-375) 
cells  /mm3.    Up  to  106  (98.1%) were quite  ill  with 
a  Karnofsky performance status of  less than 50% and 
only 62(57.4%) were receiving cotrimoxazole prophy-
laxis (table 1). Only 22 (20%) were receiving ART, with 
stavudine, lamuvidine and nevirapine (75%) common-
est ART combination according to the guidelines at that 
time.
 




Characteristic                                                                        N=108   
 
Men, number (%) 64 (59.3) 
 
Mean age in years, mean (range) 
 
33 (18-60) 
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Karnofsky score, <50, number (%) 
 
106(98.1) 
Abbreviations: SD-standard deviation, BMI-Body mass index, ART- antiretroviral therapy
Aetiology of  cervical lymphadenopathy
Out of  108 patients, only 73 had both fine needle as-
piration and biopsy done, while 35 (32.4%) had only 
fine needle aspiration, as the nodes were not easily ac-
cessible for biopsy because they were too deep or were 
fluctuant.
On  FNAC diagnosis was  65.7% tuberculosis, 10.2% 
Kaposi’s sarcoma, 7.4% non  specific reactive adenitis, 
3.7% Hodgkin’s lymphoma and one patient each 0.9% 
for NHL, toxoplasmosis and metastatic carcinoma (ta-
ble 2). Diagnosis by histology showed; 79.5% tuber-
culosis, 13.6% Kaposi’s sarcoma, 4.1% non specific 
reactive adenitis, 1.3% non Hodgkin’s lymphoma and 
1.3% secondary metastatic carcinoma (table 2). FNAC 
was not able to come up with a conclusive diagnosis in 
9.3% of  the samples obtained. Among the 58 patients 
with histological diagnosis of  TB, only 35 (60.3%) had 
a positive ZN on FNA and among the 71 patients with 
cytological diagnosis of  TB, only 48 (67.6%) had a pos-
itive ZN. KS was seen at a significantly higher CD4 
(153, SD 177) cells/mm3 as compared to tuberculosis 
whose mean CD4 cell counts was 70 (SD, 97) cells/
mm3 (p-value, 0.034). None of  the selected samples for 
quality control (10%) had a disagreement with the orig-
inal diagnosis.
 
Diagnosis FNAC Histology 
 Freq % Mean CD4 
 
(+/- SD) 







































































































Total 108 100  73 100  
Table 2.  Diagnosis  of  cervical  lymphadenopathy  and  mean  CD4  among  HIV-infected  patients  in
Uganda
Abbreviations: FNAC-Fine needle aspiration cytology; HD-Hodgkin’s disease; 
KS-Kaposis Sarcoma;NA- Not applicable; NHL-Non Hodgkin’s Lymphoma; Toxo-toxoplasmosis 
Plates A to D (figure 2) show the histological diagnosis 
of  the four commonest causes of  cervical lymphad-
enopathy. Of  the 71 patients diagnosed with TB on 
FNAC, only 48 patients (67.6%)  had  a  positive  ZN 
smear.  All  patients  had  caseous  necrosis  and  46 
(64.8)  had granulomas. 
Seventy seven percent of  the patients with lymphade-
nopathic KS had mucocutaneous lesions.
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Figure 2 : FNAC PLATES
A FNAC of  c er vi c al l ymp h nod e f  r om a 28 year ol d femal e show i ng ep i t hel oi d c el l gr anul omas (w 
hi t e ar r ow s) and c aseous nec r osi s (bl ac k ar r ow s). (Di f  f  Qui c k st ai n. Mag ni f  i c at i on x 40).
B FNAC f  r om c er vi c al l ymp h nod e of  a 24 year ol d mal e show i ng c l ust er s of  sp i nd l e c el l s (w hi t 
e ar r ow s). (H& E st ai n. Mag ni f  i c at i on x 40).
C FNAC of  a c er vi c al l ymp h nod e show i ng Reed -St er nb er g c el l s (w hi t e ar r ow ) and p op c or n c 
el l s( bl ac k ar r ow ) f  r om a 26 year ol d femal e p at i ent w i t h Hod g k i n’ s d i sease.  (H& E st ai n. Mag 
ni f  i c at i on x 40).
D FNAC f  r om a c er vi c al l ymp h nod e of  a 26 year ol d HIV p osi t i ve femal e p at i ent w i t h  a r eac t i 
ve nod e. Not e t he d i f  fer ent st ages of  l ymp hoc yt e mat ur at i on (ar r ow s). (Di f  f  Qui c k st ai n. Mag ni 
f  i c at i on x 40) FNAC-f  i ne need l e asp i r at e c yt ol og y; H& E- Hemat oxyli n and Eosi n
Duration and complications of  FNA procedure
The FNA procedure was shorter to perform as com-
pared to the biopsy. FNA took a maximum of  five 
minutes to be completed before processing. Processing 
the slide took another average of  ten minutes in the 
ward side laboratory. We recorded no immediate com-
plications with the FNA and none was reported in the 
period between doing the procedure and returning of  
the patients results. To carry out an open lymph node 
biopsy required surgical instruments, local anaesthetic 
agent, surgical sutures and draping towels. The mini-
mum time which was taken to complete an open lymph 
node biopsy was 20 minutes and processing the spec-
imen required a minimum time of  24 hours. However 
no immediate complications were reported by any pa-
tient following the biopsies from the time of  biopsy to 
the time of  returning the histology results.
Diagnostic accuracy of  FNAC
FNAC notably had a high diagnostic accuracy with a 
sensitivity of  93.1%, specificity of  100%, positive pre-
dictive value (PPV) of  100% and negative predictive 
(NPV) value of  79.9% for TB and sensitivity of  80%, 
specificity of  98.4%, PPV of  88.9% and NPV of  98.9% 
for KS when compared to histology. However, the di-
agnostic accuracy was relatively low with a sensitivity of  
66.7% and a Kappa score of  0.65 for the diagnosis of  
reactive adenitis (table 3).
Table 3.  Sensitivity, specificity, PPV, NPV, kappa statistics of FNAC compared to histology among HIV- 
infected patients in Mulago Hospital, Uganda 
 
Diagnosis Sensitivity (%) Specificity (%) PPV (%) NPV (%) Kappa score 

























TB-tuberculosis, KS- Kaposi’s sarcoma, PPV-positive predictive value, NPV-negative predictive value 
Overall, 65(89%) of  FNAC findings were in agree-
ment with the histology results for the same patients. 
For the other diagnoses the numbers were too small, to 
determine the accuracy of  FNAC. The non diagnostic 
FNACs were 10 and the main reason for these was in-
sufficient sample material from FNA according to the 
pathologist. These non diagnostic FNAs were encoun-
tered in instances where a bloody aspirate was got. Two 
of  these bloody stained aspirates, later turned out to 
be KS on lymph node biopsy. The remaining eight non 
diagnostic FNAs, a diagnosis was not made at all, since 
even the biopsy was not done due to inaccessibility of  
the nodes. One patient had both TB and KS found in 
one lymph node on FNAC.
Discussion
Diagnostic accuracy
Overall FNAC diagnosis was in agreement with histo-
logical diagnosis in more than four fifth of  the patients, 
which is quite high and shows that FNAC is generally 
a very accurate diagnostic procedure in HIV-infected 
patients with cervical lymphadenopathy. This was com-
parable to earlier studies done elsewhere.13,14 FNAC was 
able to come up with a diagnosis in 83% (29/35) pa-
tients where biopsy was not possible, emphasizing the 
diagnostic utility of  FNAC even when biopsy is diffi-
cult.15
FNAC was found to be a highly accurate method in the 
diagnosis of  TB; with a sensitivity of  over ninety per-
cent and a specificity of  100%.This compares favora-
bly with other studies done elsewhere in the developing 
world where TB is endemic.10,16 These findings were dif-
ferent from studies done in the developed world where 
TB is not endemic, where FNA was found to have a 
very low sensitivity of  46% in the diagnosis of  TBLN.17  
The ZN positive rate was over two thirds which falls 
within the reported range of  (10-77%).1,2,17  This em-
phasizes the fact that a negative ZN on FNA does not 
rule out tuberculosis.
There were no false positive diagnoses made on fine 
needle aspiration for the diagnosis of  tuberculosis; 
however there were four false negatives when com-
pared with histology the gold standard. This is compa-
rable with what previous studies found.13,18   This study 
had a lower false negative rate in TB diagnosis when 
compared to a study by Aljafari et al in Sudan  where he 
found a false negative rate of  38% using a bigger gauge 
needle.19 The difference, probably can be attributed to 
the differences in sizes of  needles used, since the bigger 
the needle the higher the chances of  haemorrhage dis-
torting the cytological picture. There was an excellent 
kappa agreement of  0.85 between FNAC and histology 
results in the diagnosis of  tuberculosis. This therefore 
means that results of  FNAC are quite comparable to 
results of  histology making it quite a  useful method in 
diagnosis of  TB adenitis even in the absence of  histol-
ogy. This therefore means that it will be a very useful 
method if  employed for use for TB diagnosis in Ugan-
da. FNAC was also highly accurate in the diagnosis of  
KS and this was comparable to what Bates et al found.18
Diagnosis of  reactive adenopathy with FNAC had a rel-
atively low sensitivity compared to other aetiologies like 
TB and KS. This clearly depicts the diagnostic pitfalls 
of  FNAC in diagnosis of  reactive adenopathy as also 
reported by Reid et al.20  The number of  patients with 
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reactive adenopathy was however quite small, and this 
may have affected the result we got. Moreover, reactive 
adenitis has been questioned as a diagnosis21. For the 
other aetiologies of  cervical lymph nodes found in our 
study, that is NHL and secondary metastatic carcinoma, 
the numbers were too small to determine the diagnostic 
accuracy of  FNA in their diagnosis. One patient had 
both TB and KS found in one lymph node on FNAC. 
A similar finding was reported by Hayes in a suspected 
HIV patient case report.22 This re-emphasizes the pos-
sibility of  two diagnoses in one node, especially in HIV 
positive patients as has been reported elsewhere.16,22 
This dual aetiology however was discovered on FNAC 
in this study, and this was possible because more than 
one pass was made through the lymph nodes at differ-
ent points.
Our study has several strengths. Our observations were 
drawn after screening over 1,200 patients in one of  only 
two national referrals hospitals in Uganda. The hospi-
tal admits patients from most of  the HIV care centers 
drawing a diverse population of  HIV patients. We were 
unable to do lymph node biopsies in 35 patients who 
had cervical lymphadenopathy, since some lymph nodes 
were very deeply seated and not easily accessible for bi-
opsy while in three patients, the nodes were fluctuant 
and not feasible for open biopsy. Biopsying a fluctuant 
lymph node carries a great risk of  fistula formation.23,24 
For such patients fine needle aspiration may be the only 
means of  making the diagnosis and guide therapy with 
great accuracy according to our study. The majority of  
patients were below the fourth decade and this made 
the likelihood of  finding other aetiologies less likely. In 
as much as this may be in agreement with the current 
demographics of  HIV infection, these results may not 
be applicable to the older population of  patients with 
HIV. Mycobacterial culture and PCR on the FNA ma-
terial were not done for TB diagnosis. These may have 
improved on the diagnostic accuracy of  FNAC and 
should be included in future studies. 
 
Aetiology of  cervical lymphadenopathy
Our study found tuberculosis to be the commonest 
cause of  cervical lymphadenopathy among the study 
patients. This was similar to what was found in pre-
vious studies done in Uganda and other developing 
countries.25-27  The percentage of  TB was higher in this 
study at 69.4% as compared to Adrigwe’s study done in 
Mulago hospital, where it was 47.5%. This difference 
may be explained by the fact that this was a slightly dif-
ferent study population. Adrigwe studied a  population 
of   both  HIV  positives  and  negative patients,  while 
only  HIV  positives  were included in our study. It has 
been demonstrated that advanced HIV infection may 
increase the diagnostic yield of  FNA. This has been at-
tributed to reduced immunological capacity of  the im-
mune system to clear off  the mycobacterium in HIV 
infected patients.
The second commonest cause of  cervical lymphade-
nopathy was Kaposi’s sarcoma causing about a tenth 
of  all adenopathies. This is comparable to the previ-
ous studies done.13,18,26 Over a third of   patients  with 
lymphadenopathic  KS  (n=10),  had  mucocutaneous 
KS  as  well,  which emphasizes the importance of  ex-
amination of  the skin and mucous membranes in HIV 
positive patients   with   lymphadenopathy,   since   it 
may   elucidate   on   the   possible   cause   of  lymphad-
enopathy.
Non specific reactive lymphadenopathy was the third 
commonest cause accounting for less than a tenth of  all 
the lymphadenopathies. This was quite different from 
what Adrigwe found among medical patients with cervi-
cal lymphadenopathy, where this accounted for (28.3%) 
of  all aetiologies.26 Other studies elsewhere also differed 
greatly from the findings of  our study, with reactive non 
specific adenitis occurring more frequently.10,13,17,28   This 
may be explained by the difference in the study popu-
lations, the patients in our study were probably more 
immune suppressed as compared to patients in other 
quoted studies above, making tuberculosis more likely 
than reactive adenitis to affect the nodes.
The majority of  the patients were very sick with Kar-
nofsky performance status of  less than 50. This may be 
because the study population constituted patients en-
tirely from the medical wards, where patients are gener-
ally very sick and confined to bed in most cases.   This 
shows that patients present late for care and may also 
explain the high mortality rate on the medical wards 
that has been reported in other studies.29,30
Key messages
•   FNAC is safe and accurate in the diagnosis of  cervi-
cal lymphadenopathic tuberculosis and Kaposis sarco-
ma among HIV positive patients with advanced disease.
•   Tuberculosis is currently the commonest cause of  
cervical lymphadenopathy among HIV patients in 
Uganda.
•   FNAC is still useful in diagnosis of  tuberculosis even 
when microscopy with Ziehl Neelsen (ZN) is negative
Conclusion
In summary, our study shows that tuberculosis is cur-
rently the commonest cause of  cervical lymphadenop-
athy among HIV patients who participated in the study. 
FNAC is an accurate diagnostic method in evaluation 
of  aetiology of  cervical lymphadenopathy among HIV 
positive individuals, especially in the diagnosis of  tuber-
culosis and Kaposi’s sarcoma. Moreover, FNA is quite 
a useful diagnostic test even where lymph node biopsy 
is not possible. However, a negative FNA on ZN test 
does not rule out tuberculous adenitis and FNAC is still 
useful in diagnosis of  tuberculosis even when ZN is 
negative.
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